-
The competing risk approach for prediction of preeclampsia.
Wright D, Wright A, Nicolaides KH.
Am J Obstet Gynecol 2020;223:12-23.e7. pdf -
Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
Mazer Zumaeta A, Wright A, Syngelaki A, Maritsa VA, Da Silva AB, Nicolaides KH.
Ultrasound Obstet Gynecol 2020;56:400-407. pdf -
Prediction of pre-eclampsia in twin pregnancies by maternal factors and biomarkers at 11-13 weeks' gestation: data from the EVENTS trial.
Benkő Z, Wright A, Rehal A, Cimpoca B, Syngelaki A, Delgado JL, Tsokaki T, De Alvarado M, Vojtassakova D, Malligiannis Ntalianis K, Chaveeva P, Del Campo A, De Ganzo T, Resta C, Atanasova V, Accurti V, Villalain C, Aguilera J, Dojcinovska D, O'gorman N, Plasencias W, Zingler E, Dutemeyer V, Alvar B, Casanova MC, Nicolaides KH.
Ultrasound Obstet Gynecol 2021;57:257-265 pdf -
Mini-combined test compared with NICE guidelines for early risk-assessment for pre-eclampsia: the SPREE diagnostic accuracy study.
Poon LC, Wright D, Thornton S, Akolekar R, Brocklehurst P, Nicolaides KH.
Southampton (UK): NIHR Journals Library 2020 pdf -
Impact of new definitions of pre-eclampsia on incidence and performance of first-trimester screening.
Khan N, Andrade W, De Castro H, Wright A, Wright D, Nicolaides KH.
Ultrasound Obstet Gynecol 2020;55:50-57. pdf -
Two-stage screening for preterm preeclampsia at 11-13 weeks' gestation.
Wright A, Wright D, Syngelaki A, Georgantis A, Nicolaides KH.
Am J Obstet Gynecol 2019;220:197.e1-197.e11. pdf -
Predictive performance of the competing risk model in screening for preeclampsia.
Wright D, Tan MY, O'Gorman N, Poon LC, Syngelaki A, Wright A, Nicolaides KH.
Am J Obstet Gynecol 2019;220:199.e1-199.e13. pdf -
Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation.
Tan MY, Syngelaki A, Poon LC, Rolnik DL, O'Gorman N, Delgado JL, Akolekar R, Konstantinidou L, Tsavdaridou M, Galeva S, Ajdacka U, Molina FS, Persico N, Jani JC, Plasencia W, Greco E, Papaioannou G, Wright A, Wright D, Nicolaides KH.
Ultrasound Obstet Gynecol 2018;52:186-195. pdf -
Management of pregnancies after combined screening for pre-eclampsia at 19-24 weeks' gestation.
Litwinska M, Syngelaki A, Wright A, Wright D, Nicolaides KH.
Ultrasound Obstet Gynecol 2018;52:365-372. pdf -
Protocol for the prospective validation study: 'Screening programme for pre-eclampsia' (SPREE)
Tan MY, Koutoulas L, Wright D, Nicolaides KH, Poon LCY.
Ultrasound Obstet Gynecol 2017;50:175-179. pdf -
Competing-risks model in screening for pre-eclampsia in twin pregnancy according to maternal factors and biomarkers at 11-13 weeks' gestation.
Francisco C, Wright D, Benkő Z, Syngelaki A, Nicolaides KH.
Ultrasound Obstet Gynecol 2017;50:589-595. pdf -
Impaired placentation in women with chronic hypertension that develop preeclampsia.
Panaitescu AM, Akolekar R, Kametas N, Syngelaki A, Nicolaides KH.
Ultrasound Obstet Gynecol 2017;50:496-500. pdf -
A study protocol for the prospective validation study: Screening programme for pre-eclampsia (SPREE)
Tan MY, Koutoulas L, Wright D, Nicolaides KH, Poon LC.
Ultrasound Obstet Gynecol 2017;50:175-179. pdf -
Multicenter screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks' gestation: comparison to NICE guidelines and ACOG recommendations.
O' Gorman N, Wright D, Poon LC, Rolnik DL, Syngelaki A, de Alvarado M, Carbone IF, Dutemeyer V, Fiolna M, Frick A, Karagiotis N, Mastrodima S, de Paco Matallana C, Papaioannou G, Pazos A, Plasencia W, Nicolaides KH.
Ultrasound Obstet Gynecol 2017;49:756-760. pdf -
Proposed clinical management of pregnancies after combined screening for preeclampsia at 35-37 weeks' gestation.
Panaitescu AM, Wright D, Militello A, Akolekar R, Nicolaides KH.
Ultrasound Obstet Gynecol 2017:50:383-387. pdf -
Proposed clinical management of pregnancies after combined screening for preeclampsia at 19-24 weeks' gestation.
Litwinska M, Wright D, Efeturk T, Ceccacci I, Nicolaides KH.
Ultrasound Obstet Gynecol 2017;50:367-372. pdf -
Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation.
O'Gorman N, Wright D, Poon LC, Rolnik DL, Syngelaki A, Wright A, Akolekar R, Cicero S, Janga D, Jani J, Molina FS, de Paco Matallana C, Papantoniou N, Persico N, Plasencia W, Singh M, Nicolaides KH.
Ultrasound Obstet Gynecol 2017;49:751-755. pdf -
Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 30-34 weeks' gestation.
Wright D, Dragan I, Syngelaki A, Akolekar R, Nicolaides KH.
Ultrasound Obstet Gynecol 2017;49:194-200. pdf -
Inverted Pyramid of Care.
Sonek JD, Kagan KO, Nicolaides KH.
Clin Lab Med 2016;36:305-17. pdf -
First trimester prediction of HELLP syndrome.
Oliveira N, Poon LC, Nicolaides KH, Baschat AA.
Prenat Diagn 2016;36:29-33. pdf